265 related articles for article (PubMed ID: 18490300)
21. Left ventricular apical aneurysm: a novel phenotype of Fabry's disease.
Agarwal A; Malik A; DeFranco AC; Tajik AJ
Eur Heart J Cardiovasc Imaging; 2014 May; 15(5):585. PubMed ID: 24196119
[No Abstract] [Full Text] [Related]
22. Cerebral hemorrhage in Fabry's disease.
Nakamura K; Sekijima Y; Nakamura K; Hattori K; Nagamatsu K; Shimizu Y; Yasude T; Ushiyama M; Endo F; Fukushima Y; Ikeda S
J Hum Genet; 2010 Apr; 55(4):259-61. PubMed ID: 20300124
[TBL] [Abstract][Full Text] [Related]
23. Fabry's disease with LVOT obstruction: diagnosis and management.
Blount JR; Wu JK; Martinez MW
J Card Surg; 2013 Nov; 28(6):695-8. PubMed ID: 23992477
[TBL] [Abstract][Full Text] [Related]
24. New insights in cardiac structural changes in patients with Fabry's disease.
Linhart A; Palecek T; Bultas J; Ferguson JJ; Hrudová J; Karetová D; Zeman J; Ledvinová J; Poupetová H; Elleder M; Aschermann M
Am Heart J; 2000 Jun; 139(6):1101-8. PubMed ID: 10827394
[TBL] [Abstract][Full Text] [Related]
25. Significance of asymmetric basal posterior wall thinning in patients with cardiac Fabry's disease.
Kawano M; Takenaka T; Otsuji Y; Teraguchi H; Yoshifuku S; Yuasa T; Yu B; Miyata M; Hamasaki S; Minagoe S; Kanmura Y; Tei C
Am J Cardiol; 2007 Jan; 99(2):261-3. PubMed ID: 17223430
[TBL] [Abstract][Full Text] [Related]
26. MRI characterization of myocardial tissue in patients with Fabry's disease.
Imbriaco M; Spinelli L; Cuocolo A; Maurea S; Sica G; Quarantelli M; Pisani A; Liuzzi R; Cianciaruso B; Sabbatini M; Salvatore M
AJR Am J Roentgenol; 2007 Mar; 188(3):850-3. PubMed ID: 17312078
[TBL] [Abstract][Full Text] [Related]
27. Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat.
Germain DP; Hughes DA; Nicholls K; Bichet DG; Giugliani R; Wilcox WR; Feliciani C; Shankar SP; Ezgu F; Amartino H; Bratkovic D; Feldt-Rasmussen U; Nedd K; Sharaf El Din U; Lourenco CM; Banikazemi M; Charrow J; Dasouki M; Finegold D; Giraldo P; Goker-Alpan O; Longo N; Scott CR; Torra R; Tuffaha A; Jovanovic A; Waldek S; Packman S; Ludington E; Viereck C; Kirk J; Yu J; Benjamin ER; Johnson F; Lockhart DJ; Skuban N; Castelli J; Barth J; Barlow C; Schiffmann R
N Engl J Med; 2016 Aug; 375(6):545-55. PubMed ID: 27509102
[TBL] [Abstract][Full Text] [Related]
28. Detection of Urinary Mulberry Bodies Leads to Diagnosis of Fabry Cardiomyopathy: A Simple Clue in the Urine Sediment.
Yano T; Takahashi R; Yamashita T; Nagano N; Ishikawa A; Sakurai A; Maruyama H; Miura T
Circ Heart Fail; 2017 Dec; 10(12):. PubMed ID: 29203563
[No Abstract] [Full Text] [Related]
29. Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients.
Tanaka M; Ohashi T; Kobayashi M; Eto Y; Miyamura N; Nishida K; Araki E; Itoh K; Matsushita K; Hara M; Kuwahara K; Nakano T; Yasumoto N; Nonoguchi H; Tomita K
Clin Nephrol; 2005 Oct; 64(4):281-7. PubMed ID: 16240899
[TBL] [Abstract][Full Text] [Related]
30. Fabry's disease presenting with stroke.
Grewal RP; Barton NW
Clin Neurol Neurosurg; 1992; 94(2):177-9. PubMed ID: 1324819
[TBL] [Abstract][Full Text] [Related]
31. Reduction in ECG abnormalities and improvement of regional left ventricular function in a patient with Fabry's disease during enzyme-replacement therapy.
Prinz C; Farr M; Hering D; Horstkotte D; Faber L
Clin Res Cardiol; 2010 Jan; 99(1):53-5. PubMed ID: 19774328
[No Abstract] [Full Text] [Related]
32. [End-stage cardiac manifestations and autopsy findings in patients with cardiac fabry disease].
Teraguchi H; Takenaka T; Yoshida A; Taguchi S; Ninomiya K; Yoshida H; Horinouchi M; Yonezawa S; Nakao S; Minagoe S; Tei S
J Cardiol; 2004 Feb; 43(2):98-9. PubMed ID: 15046052
[TBL] [Abstract][Full Text] [Related]
33. [Electrocardiogram in Fabry's disease].
Jastrzebski M; Petkow-Dimitrow P
Kardiol Pol; 2008 Jun; 66(6):688-92; discussion 692-3. PubMed ID: 18626840
[No Abstract] [Full Text] [Related]
34. Cardiac abnormalities in Anderson-Fabry disease and Fabry's cardiomyopathy.
Morrissey RP; Philip KJ; Schwarz ER
Cardiovasc J Afr; 2011; 22(1):38-44. PubMed ID: 21298206
[TBL] [Abstract][Full Text] [Related]
35. Apical left ventricular hypertrophy and mid-ventricular obstruction in fabry disease.
Cianciulli TF; Saccheri MC; Fernández SP; Fernández CC; Rozenfeld PA; Kisinovsky I
Echocardiography; 2015 May; 32(5):860-3. PubMed ID: 25684266
[TBL] [Abstract][Full Text] [Related]
36. [Ocular findings in Fabry's disease].
Kuzman T; Juri J; Mrsić M; Jeren-Strujić B; Mandić Z; Sikić J
Acta Med Croatica; 2006; 60(2):163-6. PubMed ID: 16848212
[TBL] [Abstract][Full Text] [Related]
37. Unexplained left ventricular hypertrophy: consider a diagnosis of Fabry's disease.
Linthorst GE; Vedder AC; Bouma BJ; Dekker LR; Hollak CE
Neth Heart J; 2006 Mar; 14(3):100-105. PubMed ID: 25696603
[TBL] [Abstract][Full Text] [Related]
38. Ventricular fibrillation refractory to automatic internal cardiac defibrillator in Fabry's disease. Review of cardiovascular manifestations.
Eckart RE; Kinney KG; Belnap CM; Le TD
Cardiology; 2000; 94(3):208-12. PubMed ID: 11279328
[TBL] [Abstract][Full Text] [Related]
39. [Complete atrioventricular block disclosing Fabry's disease].
Elhadad S; Melet V; Domniez T; Cosson S; Chollet D; Vedel J
Arch Mal Coeur Vaiss; 1997 Mar; 90(3):393-7. PubMed ID: 9232078
[TBL] [Abstract][Full Text] [Related]
40. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study.
Takenaka T; Teraguchi H; Yoshida A; Taguchi S; Ninomiya K; Umekita Y; Yoshida H; Horinouchi M; Tabata K; Yonezawa S; Yoshimitsu M; Higuchi K; Nakao S; Anan R; Minagoe S; Tei C
J Cardiol; 2008 Feb; 51(1):50-9. PubMed ID: 18522775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
